Kalaris Therapeutics, Inc. (KLRS)
6.10
-0.23
(-3.63%)
USD |
NASDAQ |
Apr 23, 16:00
6.05
-0.05
(-0.82%)
After-Hours: 20:00
Kalaris Therapeutics EPS Diluted (Quarterly) : -0.4366 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Agenus, Inc. | -0.301 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
| Arrowhead Pharmaceuticals, Inc. | 0.219 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.998M |
| Total Expenses (Quarterly) | 9.998M |
| Enterprise Value | 23.33M |
| Earnings Yield | -68.77% |
| Normalized Earnings Yield | -72.76 |